{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:30:54Z","timestamp":1791549054597,"version":"4.3.4"},"reference-count":66,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>2022 was a landmark year with two adeno\u2010associated viral vectors (AAVs) receiving conditional marketing authorization from EMA for the treatment of persons with severe haemophilia A and severe to moderately severe haemophilia B and a third in 2024. Gene therapy is a transformative, irreversible treatment with long\u2010lasting effects, necessitating development of new clinical pathways to ensure optimal outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To develop a consensus framework and service specification for delivery of AAV gene therapy for haemophilia in adults within the UK using the hub\u2010and\u2010spoke model proposed by the European Association of Haemophilia and Allied Disorders and the European Haemophilia Consortium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The UK Haemophilia Centre Doctors Organisation (UKHCDO) set up a working party to develop expert consensus guidance, working with NHS England to ensure alignment with NHS England commissioning and the national service specification.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>These guidelines detail the patient pathway, counselling and governance requirements for the hub\u2010and\u2010spoke model. The national service specification requires the hub site to manage governance for AAV\u2010based gene therapy. Proposed regional and national multidisciplinary teams will harmonize clinical practices incorporating expertise from various specialities and professional groups. Key requirements identified include standardized documentation and multidisciplinary collaboration. Nationally agreed patient information and counselling checklists will streamline the informed consent process and facilitate data collection for long\u2010term safety and efficacy monitoring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These guidelines provide a structured framework for the delivery of liver\u2010directed gene therapy. Whilst specific to the United Kingdom they provide a framework for the implementation of gene therapy in other countries for haemophilia and other monogenic disorders.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.15125","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:44:05Z","timestamp":1732121045000},"page":"26-38","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults"],"prefix":"10.1111","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-1051","authenticated-orcid":false,"given":"Pratima","family":"Chowdary","sequence":"first","affiliation":[{"name":"Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital  London UK"},{"name":"Department of Haematology Cancer Institue University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Duran","sequence":"additional","affiliation":[{"name":"Pharmacy Department Manchester University NHS Foundation Trust  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Batty","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital  London UK"},{"name":"Department of Haematology Cancer Institue University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Lowe","sequence":"additional","affiliation":[{"name":"West Midlands Adult Comprehensive Care Haemophilia Centre Queen Elizabeth Hospital  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Jones","sequence":"additional","affiliation":[{"name":"Haemophilia Centre Royal Victoria Infirmary The Newcastle upon Tyne Hospitals NHS Foundation Trust  Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Pollard","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boyce","sequence":"additional","affiliation":[{"name":"University Hospital Southampton Haemophilia Comprehensive Care Centre  Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Motwani","sequence":"additional","affiliation":[{"name":"Department of Haematology Birmingham Children's Hospital  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Amirloo","sequence":"additional","affiliation":[{"name":"Pharmacy Department Manchester University NHS Foundation Trust  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Musgrave","sequence":"additional","affiliation":[{"name":"Haemophilia Centre Royal Victoria Infirmary The Newcastle upon Tyne Hospitals NHS Foundation Trust  Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hopper","sequence":"additional","affiliation":[{"name":"Haemophilia Centre Royal Victoria Infirmary The Newcastle upon Tyne Hospitals NHS Foundation Trust  Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Classey","sequence":"additional","affiliation":[{"name":"Centre for Haemostasis and Thrombosis Guy's and St Thomas NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Whitaker","sequence":"additional","affiliation":[{"name":"Southern Haemophilia Network Basingstoke and North Hampshire Hospital  Basingstoke UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dunn","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-5848","authenticated-orcid":false,"given":"Annette","family":"Bowyer","sequence":"additional","affiliation":[{"name":"Department of Coagulation Royal Hallamshire Hospital  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-5829","authenticated-orcid":false,"given":"Susan","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Oxford Haemophilia and Thrombosis Centre Oxford University Hospitals  Oxford UK"},{"name":"Radcliffe Department of Medicine Oxford University  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.232132"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1829"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100890"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2971"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00487-6"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature15818"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000540"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-306647"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302364"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407309"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.169"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.01.026"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004625"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2113708"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211644"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708538"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043021-033013"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.08.015"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.029"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.12.033"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12177"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00341"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101126"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.03.004"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119913"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658038"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000388"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01751-0"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708483"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.15064"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007435"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15281"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.23.14793-14803.2005"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000985"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1991.tb04964.x"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3389"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318281"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.52"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142658"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.06.004"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.07.012"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13915"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009876"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14420"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14546"},{"key":"e_1_2_17_50_1","unstructured":"EMA.Advanced therapy medicinal products: overview.2023. Accessed June 1 2024.https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/advanced\u2010therapy\u2010medicinal\u2010products\u2010overview#publications\u201018733"},{"key":"e_1_2_17_51_1","unstructured":"EMA.Guideline on the quality non\u2010clinical and clinical aspects of gene therapy medicinal products.2018. Accessed June 1 2024.https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/guideline\u2010quality\u2010non\u2010clinical\u2010and\u2010clinical\u2010aspects\u2010gene\u2010therapy\u2010medicinal\u2010products_en.pdf"},{"key":"e_1_2_17_52_1","unstructured":"SPS\u2010UK.The role of pharmacy in the successful delivery of advanced therapy medicinal products (ATMPs): NHS Pharmaceutical Quality Assurance Committee; National Pharmacy Clinical Trials Advisory Group.2017. Accessed June 1 2024.https:\/\/www.sps.nhs.uk\/wp\u2010content\/uploads\/2017\/08\/ATMP\u2010Final\u2010yellow.pdf"},{"key":"e_1_2_17_53_1","unstructured":"SPS\u2010UK.Gene therapy medicinal products: governance and preparation requirements version 3 by Pan UK Pharmacy Working Group for ATMPs.2024. Accessed June 1 2024.https:\/\/www.sps.nhs.uk\/wp\u2010content\/uploads\/2024\/02\/PAN\u2010UK\u2010PWG\u2010for\u2010ATMPs\u2010Gene\u2010Therapy\u2010Guidance\u2010V3.pdf"},{"key":"e_1_2_17_54_1","unstructured":"SPS\u2010UK.How to perform preparation risk assessments for ATMPs.2024. Accessed June 3 2024.https:\/\/www.sps.nhs.uk\/articles\/how\u2010to\u2010perform\u2010preparation\u2010risk\u2010assessments\u2010for\u2010atmps"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100759"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/26330040211047244"},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13769"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.17225\/jhp00174"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14378"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S239810"},{"key":"e_1_2_17_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02256-2"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14572"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14188"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14545"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.07.016"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15023"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008948"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.15125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:21:55Z","timestamp":1738214515000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.15125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/hae.15125"],"URL":"https:\/\/doi.org\/10.1111\/hae.15125","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"2024-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}